相关实验视频
Updated: Jun 25, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.5K
在乳腺癌中,基因甲基化基因生物年龄的化疗诱导加速
Drew R Nannini1, Rene Cortese2,3, Christopher VonTungeln1
1Department of Internal Medicine, School of Medicine, University of Missouri at Columbia, Columbia, MO, USA.
Epigenetics
|May 31, 2024
概括
乳腺癌的化疗加快了生物衰老,正如DNA甲基化标记所示. 这表明细胞毒性疗法会影响衰老,并可能影响幸存者的长期健康.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 在瘤学瘤学.
- 衰老研究研究 衰老研究
背景情况:
- 乳腺癌是女性的主要诊断,经常用化疗治疗.
- 以前的研究表明,化疗可能会增加生物年龄.
- DNA甲基化标记提供了一种评估化疗对衰老影响的新方法.
研究的目的:
- 研究化疗与乳腺癌患者生物衰老的DNA甲基化基标记物之间的关联.
主要方法:
- 在第一个化疗周期前后,对来自18名乳腺癌患者的血液样本进行了DNA甲基化分析.
- 估计了六个生物衰老加速和端粒长度的标志物.
- 用多个线性回归分析来评估化疗与衰老标志物之间的关联.
主要成果:
- 在化疗后,观察到内在表观遗传年龄加速,外在表观遗传年龄加速,PhenoAge加速,GrimAge加速和DunedinPACE的显著增加.
- 在化疗后,端粒长度显著减少.
- 这些变化表明,在第一个化疗周期后,生物衰老加速.
结论:
- 化疗与乳腺癌患者的加速生物衰老有关,通过DNA甲基化测量.
- 细胞毒性疗法可能会影响癌症患者的衰老过程.
- 这些发现对了解癌症幸存者的与年龄有关的健康状况有意义.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

